Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Proteins|February 22, 2011
An accurate model of polyglutamineJyothi L Digambaranath, Tyler V Campbell, Alfred Chung, et al.
Immunotherapy|October 17, 2025
How should we choose optimal salvage treatments following BCMA-directed CAR T-cell therapy?Arvind Suresh, Darren Pan, Jodi Lipof, et al.
Chemical Biology & Drug Design|October 24, 2007
Microwave-assisted solid-phase peptide synthesis utilizing N-Fmoc-protected (alpha-aminoacyl)benzotriazolesAlan R Katritzky, Niveen M Khashab, Megumi Yoshioka, et al.
Blood Advances|February 7, 2020
Organ responses with daratumumab therapy in previously treated AL amyloidosisAlfred Chung, Gregory P Kaufman, Surbhi Sidana, et al.
Expert Opinion on Investigational Drugs|May 27, 2025
Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive reviewDarren Pan, Anupama Kumar, Jodi J Lipof, et al.
Pacing and Clinical Electrophysiology : PACE|March 20, 2022
Ventricular tachycardia from myocarditis following COVID-19 vaccination with tozinameran (BNT162b2, Pfizer-BioNTech)Weiqin Lin, Alfred Chung Lum Yip, Lauren Kay Mance Evangelista, et al.
BMJ Supportive & Palliative Care|January 9, 2026
Evidence-based intervention to prevent professional burnout in resident oncology doctors in a tertiary UK centre: a pilot studyAlfred Chung Pui So, Sarah Hunter, Karen Chan, et al.
Transplantation and Cellular Therapy|May 27, 2023
Intensity of Cyclophosphamide-Based Bridging Therapy Before Chimeric Antigen Receptor T Cell Therapy in MyelomaAneeqa Zafar, Chiung-Yu Huang, Mimi Lo, et al.
Blood Advances|December 27, 2024
BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvementMahmoud R Gaballa, Omar Castaneda Puglianini, Adam Cohen, et al.
Leukemia & Lymphoma|April 25, 2023
Significance of the pee-value: relevance of 24-hour urine studies for patients with myelomaKelsey H Natsuhara, Chiung-Yu Huang, Jennifer Knoche, et al.
Pageof 4